These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Clarkson TB; Anthony MS; Mikkola TS; St Clair RW Stroke; 2002 Nov; 33(11):2700-3. PubMed ID: 12411664 [TBL] [Abstract][Full Text] [Related]
3. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251 [TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Adams MR; Register TC; Golden DL; Wagner JD; Williams JK Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):217-21. PubMed ID: 9012659 [TBL] [Abstract][Full Text] [Related]
5. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. Williams JK; Honoré EK; Washburn SA; Clarkson TB J Am Coll Cardiol; 1994 Dec; 24(7):1757-61. PubMed ID: 7963125 [TBL] [Abstract][Full Text] [Related]
6. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. Clarkson TB; Anthony MS; Wagner JD J Clin Endocrinol Metab; 2001 Nov; 86(11):5396-404. PubMed ID: 11701713 [TBL] [Abstract][Full Text] [Related]
7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658 [TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425 [TBL] [Abstract][Full Text] [Related]
9. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126 [TBL] [Abstract][Full Text] [Related]
10. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613 [TBL] [Abstract][Full Text] [Related]
11. Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys. Shadoan MK; Anthony MS; Rankin SE; Clarkson TB; Wagner JD Metabolism; 2003 Sep; 52(9):1085-91. PubMed ID: 14506611 [TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
15. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy. Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084 [TBL] [Abstract][Full Text] [Related]
16. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [TBL] [Abstract][Full Text] [Related]
17. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383 [TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women. Williams JK; Suparto I ILAR J; 2004; 45(2):139-46. PubMed ID: 15111733 [TBL] [Abstract][Full Text] [Related]
19. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Lamon-Fava S; Postfai B; Diffenderfer M; DeLuca C; O'Connor J; Welty FK; Dolnikowski GG; Barrett PH; Schaefer EJ Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):385-91. PubMed ID: 16339502 [TBL] [Abstract][Full Text] [Related]
20. Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women. Ko HS; Kim CJ; Ryu WS Korean J Intern Med; 2005 Mar; 20(1):33-9. PubMed ID: 15906951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]